GSK Study BAM114341: A phase 2, multi-centre, randomised, double-masked, placebo-controlled, parallel-group study to investigate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GSK933776 in adult patients with geographic atr

Project: Other project

Project Details

StatusFinished
Effective start/end date3/24/1112/31/16

Funding

  • GlaxoSmithKline Pharmaceuticals: $169,600.97